[go: up one dir, main page]

FR2732219B1 - PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MALARIA, BASED ON A MEMBER OF THE CHONDROITINE-GLYCOSAMINOGLYCAN FAMILY - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MALARIA, BASED ON A MEMBER OF THE CHONDROITINE-GLYCOSAMINOGLYCAN FAMILY

Info

Publication number
FR2732219B1
FR2732219B1 FR9503565A FR9503565A FR2732219B1 FR 2732219 B1 FR2732219 B1 FR 2732219B1 FR 9503565 A FR9503565 A FR 9503565A FR 9503565 A FR9503565 A FR 9503565A FR 2732219 B1 FR2732219 B1 FR 2732219B1
Authority
FR
France
Prior art keywords
chondroitine
malaria
prevention
treatment
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9503565A
Other languages
French (fr)
Other versions
FR2732219A1 (en
Inventor
Jurg Gysin
Bruno Pouvelle
Arthur Scherf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to FR9503565A priority Critical patent/FR2732219B1/en
Priority to AU53375/96A priority patent/AU5337596A/en
Priority to PCT/FR1996/000458 priority patent/WO1996030026A1/en
Publication of FR2732219A1 publication Critical patent/FR2732219A1/en
Application granted granted Critical
Publication of FR2732219B1 publication Critical patent/FR2732219B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9503565A 1995-03-27 1995-03-27 PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MALARIA, BASED ON A MEMBER OF THE CHONDROITINE-GLYCOSAMINOGLYCAN FAMILY Expired - Fee Related FR2732219B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9503565A FR2732219B1 (en) 1995-03-27 1995-03-27 PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MALARIA, BASED ON A MEMBER OF THE CHONDROITINE-GLYCOSAMINOGLYCAN FAMILY
AU53375/96A AU5337596A (en) 1995-03-27 1996-03-27 Pharmaceutical compositions for preventing and treating mala ria, based on a member of the chondroitin-glycosaminoglycan family
PCT/FR1996/000458 WO1996030026A1 (en) 1995-03-27 1996-03-27 Pharmaceutical compositions for preventing and treating malaria, based on a member of the chondroitin-glycosaminoglycan family

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9503565A FR2732219B1 (en) 1995-03-27 1995-03-27 PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MALARIA, BASED ON A MEMBER OF THE CHONDROITINE-GLYCOSAMINOGLYCAN FAMILY

Publications (2)

Publication Number Publication Date
FR2732219A1 FR2732219A1 (en) 1996-10-04
FR2732219B1 true FR2732219B1 (en) 1997-05-30

Family

ID=9477446

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9503565A Expired - Fee Related FR2732219B1 (en) 1995-03-27 1995-03-27 PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MALARIA, BASED ON A MEMBER OF THE CHONDROITINE-GLYCOSAMINOGLYCAN FAMILY

Country Status (3)

Country Link
AU (1) AU5337596A (en)
FR (1) FR2732219B1 (en)
WO (1) WO1996030026A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703386D0 (en) * 1997-09-19 1997-09-19 Karolinska Innovations Ab Malaria polypeptides
US6037333A (en) * 1998-05-07 2000-03-14 Trustees Of Tufts College Microbe-inhibiting compositions
AU7751301A (en) * 2000-05-31 2001-12-11 Pasteur Institut Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503563A1 (en) * 1981-04-09 1982-10-15 Pos Lab COMPOSITION FOR COLLONS BASED ON CHONDROITIN SULFATE A
JPS6320141A (en) * 1986-07-15 1988-01-27 Kawasaki Steel Corp Continuous casting method for cast strip
JPH0753388A (en) * 1993-08-12 1995-02-28 Lion Corp Bone metabolism improver

Also Published As

Publication number Publication date
WO1996030026A1 (en) 1996-10-03
FR2732219A1 (en) 1996-10-04
AU5337596A (en) 1996-10-16

Similar Documents

Publication Publication Date Title
MA26618A1 (en) PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA
MA26790A1 (en) DIETETIC OR PHARMACEUTICAL COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF HYPER-OXALURIA
FR2710541B1 (en) Set for the introduction of a catheter.
FR2710540B1 (en) Set for the introduction of a catheter.
MA26536A1 (en) COMBINATION OF PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN AND ANTIHYPERTENSITIVE AGENTS, AND PROCESS FOR THEIR PREPARATION.
DZ2494A1 (en) Pharmaceutical composition of omeprazole.
FR11C0007I2 (en) PHARMACEUTICAL COMPOSITION STABILIZED USING A BASIC AGENT
FR2720002B1 (en) Incision device for the dermal administration of a medicament.
MA26507A1 (en) AEROSOL PHARMACEUTICAL COMPOSITIONS
MA26586A1 (en) PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF SEXUAL DYSFUNCTION AND COMPOSITIONS CONTAINING SAME
FI953915A0 (en) For the relief of Dupuytren's disease
FR2742657B1 (en) COMPOSITIONS FOR THE TREATMENT OF KERATINIC MATERIALS COMPRISING THE ASSOCIATION OF A POLYAMPHOLYTE POLYMER AND A CATIONIC POLYMER
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
FR2691065B1 (en) NEW EYE COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF CERTAIN VISION DISORDERS.
FR2705966B1 (en) Antifoam compositions useful in particular for the treatment of gastric disorders.
ZA968990B (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
FR2678170B1 (en) ORAL COMPOSITIONS FOR THE PREVENTION OF ODONTONECROSE AND PARADENTARY DISEASE.
FR2712495B1 (en) Application of Óoenotheine B to obtain a medicament intended for the treatment of disorders linked to hyperandrogenism, and the pharmaceutical compositions containing it.
PH31643A (en) 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease.
FR2732219B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MALARIA, BASED ON A MEMBER OF THE CHONDROITINE-GLYCOSAMINOGLYCAN FAMILY
DZ2564A1 (en) Pharmaceutical compositions for the treatment of diabetes mellitus and associated conditions.
FR2716623B1 (en) Use of a tricyclic derivative for obtaining medicaments intended for the treatment of mnemo-cognitive disorders.
FR2705895B1 (en) Medication tablets free of lubricating agent.
FR2714603B1 (en) Dermatological composition and its use for the preparation of a medicament.
FR2718024B1 (en) Medicine and pharmaceutical composition for the treatment of inflammation.

Legal Events

Date Code Title Description
ST Notification of lapse